Dipankar Bhattacharjee, who has served as CEO of Teva Generics Europe since April 2013, will replace Siggi Olafsson, who will retire at the end of the first quarter of 2017.
Teva Pharmaceuticals and Syqe Medical say the device is the first in the medical cannabis sector that complies with pharmaceutical standards for inhalation.
Teva shares hammered a second day after disappointing third quarter | After two tough quarters, Delta-Galil profit climbs 31% | Tel Aviv has another quiet day as Wall Street opens lower
Bloomberg News report says first charges in wide-ranging investigation could come next month. News of the investigation comes at a sensitive time for the global drug industry, which has been stung by repeated charges of price gouging.
Platform will monitor and analyze key symptoms of neurodegenerative disease that impact daily living.
Anda, the fourth-largest U.S. distributor of generic pharmaceuticals, is on track to earn $1.5 billion in third-party net revenue and 15 cents in earnings per share.